These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 28393181

  • 1. MicroRNA-based molecular classification of papillary thyroid carcinoma.
    Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M.
    Int J Oncol; 2017 May; 50(5):1767-1777. PubMed ID: 28393181
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I, Al-Abdallah A, Ali RH, Al-Brahim N, Mojiminiyi O.
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN.
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [Abstract] [Full Text] [Related]

  • 5. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
    Graham ME, Hart RD, Douglas S, Makki FM, Pinto D, Butler AL, Bullock M, Rigby MH, Trites JR, Taylor SM, Singh R.
    J Otolaryngol Head Neck Surg; 2015 Sep 05; 44(1):33. PubMed ID: 26341226
    [Abstract] [Full Text] [Related]

  • 6. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH, He XM, Deng X, Ji YC, Yang H, Cheng L, Zhou XY.
    J Clin Lab Anal; 2021 Sep 05; 35(9):e23907. PubMed ID: 34268792
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
    Dettmer M, Vogetseder A, Durso MB, Moch H, Komminoth P, Perren A, Nikiforov YE, Nikiforova MN.
    J Clin Endocrinol Metab; 2013 Jan 05; 98(1):E1-7. PubMed ID: 23150679
    [Abstract] [Full Text] [Related]

  • 8. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.
    Endocr Pathol; 2015 May 05; 26(2):157-63. PubMed ID: 25771986
    [Abstract] [Full Text] [Related]

  • 9. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
    Yu S, Liu X, Zhang Y, Li J, Chen S, Zheng H, Reng R, Zhang C, Chen J, Chen L.
    Oncotarget; 2016 Dec 20; 7(51):84165-84177. PubMed ID: 27705935
    [Abstract] [Full Text] [Related]

  • 10. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL, Zhang H, Chen YL, Peng L.
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar 08; 46(3):160-165. PubMed ID: 28297755
    [Abstract] [Full Text] [Related]

  • 11. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
    Peng Y, Li C, Luo DC, Ding JW, Zhang W, Pan G.
    Molecules; 2014 Aug 05; 19(8):11586-99. PubMed ID: 25100252
    [Abstract] [Full Text] [Related]

  • 12. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
    Czajka AA, Wójcicka A, Kubiak A, Kotlarek M, Bakuła-Zalewska E, Koperski Ł, Wiechno W, Jażdżewski K.
    PLoS One; 2016 Aug 05; 11(3):e0151968. PubMed ID: 27011326
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB.
    Cancer; 2013 Dec 15; 119(24):4358-65. PubMed ID: 24301304
    [Abstract] [Full Text] [Related]

  • 14. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.
    Chruścik A, Lam AK.
    Exp Mol Pathol; 2015 Dec 15; 99(3):393-8. PubMed ID: 26321247
    [Abstract] [Full Text] [Related]

  • 15. MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report.
    Geraldo MV, Fuziwara CS, Friguglieti CU, Costa RB, Kulcsar MA, Yamashita AS, Kimura ET.
    Arq Bras Endocrinol Metabol; 2012 Nov 15; 56(8):552-7. PubMed ID: 23295297
    [Abstract] [Full Text] [Related]

  • 16. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
    Liu L, Wang J, Li X, Ma J, Shi C, Zhu H, Xi Q, Zhang J, Zhao X, Gu M.
    Biochem Biophys Res Commun; 2015 Feb 20; 457(4):621-6. PubMed ID: 25603050
    [Abstract] [Full Text] [Related]

  • 17. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
    Titov SE, Demenkov PS, Ivanov MK, Malakhina ES, Poloz TL, Tsivlikova EV, Ganzha MS, Shevchenko SP, Gulyaeva LF, Kolesnikov NN.
    Oncol Rep; 2016 Nov 20; 36(5):2501-2510. PubMed ID: 27666315
    [Abstract] [Full Text] [Related]

  • 18. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z, Yuan Z, Fan Y, Deng X, Zheng Q.
    Mol Med Rep; 2013 Nov 20; 8(5):1353-8. PubMed ID: 24064622
    [Abstract] [Full Text] [Related]

  • 19. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas.
    Borrelli N, Denaro M, Ugolini C, Poma AM, Miccoli M, Vitti P, Miccoli P, Basolo F.
    Mod Pathol; 2017 Jan 20; 30(1):39-51. PubMed ID: 27586203
    [Abstract] [Full Text] [Related]

  • 20. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P.
    Endocr Relat Cancer; 2011 Oct 20; 18(5):579-94. PubMed ID: 21778212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.